Pfizer Board of Directors

Get the latest insights into the leadership at Pfizer. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Prajeet NairDirector - Corporate Services & Company Secretary
Pradip ShahChairman
Meena GaneshNon Executive Independent Director
L KrishnakumarNon Executive Independent Director
Meenakshi NevatiaManaging Director
Sonia SinghNon Executive Independent Director
Amit AgarwalWhole Time Director - Finance & Chief Financial Officer
P RenganWhole Time Director - Plant Operations

Pfizer Share price

PFIZER

4782.8

18.70 (0.39%)
NSE
BSE
Last updated on 23 Apr, 2026 | 14:44 IST
Today's High

4824.40

Today's Low

4740.00

52 Week Low

4100.10

52 Week High

5993.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Pfizer FAQs

The board at Pfizer consists of experienced professionals, including Prajeet Nair, Pradip Shah, and others, overseeing the company’s strategic and corporate governance.

Directors at Pfizer are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Prajeet Nair is the current chairman at Pfizer.

Executive directors at Pfizer are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Pfizer adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Pfizer, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost